Literature DB >> 666426

Delayed postoperative cardiac tamponade: diagnosis and management.

R L Hardesty, M Thompson, D B Lerberg, R D Siewers, J D O'Toole, R Salerni, H T Bahnson.   

Abstract

Symptoms and signs of decreased cardiac output associated with an elevated venous pressure should alert one to the possibility of delayed cardiac tamponade. Enlargement of the cardiothoracic ratio shown by serial roentgenograms and demonstration of significant pericardial effusion by echocardiogram or radionuclide angiocardiography support the diagnosis. Erratic response of the prothrombin time to administration of warfarin and abnormal results of liver function test are additional clues to its diagnosis. Right heart catheterization documents the presence of tamponade and excludes other diagnostic considerations. Operative decompression of the pericardial space can be accomplished by pericardicentesis, subxiphoid pericardiotomy, median sternotomy, or thoracotomy. Hemodynamic observations following the relief of tamponade assure that an adequate therapeutic procedure has been performed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666426     DOI: 10.1016/s0003-4975(10)63659-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Raised international normalised ratio (INR): is it a cause or an effect of late cardiac tamponade?

Authors:  P S Wong; W B Pugsley
Journal:  Br Heart J       Date:  1992-08

2.  Late cardiac tamponade in children. A lethal complication.

Authors:  I L Kron; K Rheuban; S P Nolan
Journal:  Ann Surg       Date:  1984-02       Impact factor: 12.969

Review 3.  Management of patients after coronary artery bypass grafting surgery: a guide for primary care practitioners.

Authors:  Dominique de Waard; Andrew Fagan; Christo Minnaar; David Horne
Journal:  CMAJ       Date:  2021-05-10       Impact factor: 8.262

Review 4. 

Authors:  Dominique de Waard; Andrew Fagan; Christo Minnaar; David Horne
Journal:  CMAJ       Date:  2021-07-19       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.